Social Listening and Therapy Insights: Doctors and Their Perspectives
Understanding the HCP mindset, their informational needs, concerns, and challenges faced in day-to-day clinical practice is the first step in adding value as an entity – be it a brand, a pharmaceutical company or a platform engaging doctors. Bridging these gaps with focused and specific content, while aligning it with therapeutic and brand objectives is next. More specialized an HCP is, more specific will be his/her informational requirements. In an endeavor towards catering to the needs of the medical fraternity, measuring the pulse of the population is key.
Designing Customer Experience for Pharma Marketing
HCPs increasingly want their experience with Pharma companies to be truly personalized, authentic, and built around their individual needs. In the Decision Journey of doctors, they face different mental barriers before they can move to the next stage. The key to overcoming these barriers is ENGAGEMENT with the HCP. MedSynapse works with its clients in Pharmaceutical Industry to manage the customer experience of doctors for product marketing with its innovative CXCenter offering.
Why Pharma Websites/Apps Fail in HCP Engagement and How to Fix it
Most leading pharma companies have already launched thousands of apps on Google Play Store and iOS Appstore. Surprisingly, the total app downloads by physicians for proprietary Pharma apps around the globe is below 100,000. The propriety pharma websites on specific brands and therapy area have no different fate with poor traffic and minimal HCP engagement.…
11 Key Drivers for Success of Webinars for Doctors
Master the Execution of Webinars by learning 11 key Drivers for Success of Webinars for Doctors In our last insights article on the ‘ROI for Web Events’, we discussed Why the return on investment is higher on digital Web Events. Having addressed the ‘Why’ question, we move on to answering ‘How’ the webinar needs to…
The Art of Storytelling for Pharma Marketing
In any business, telling your brand story is a critical part of building trust with your customers. It helps shape the views and perception of your audience and they start feeling and emotional connect with your brand. When the story is told right, there is no other tool as powerful as this to build a…
Content is Still the King in Pharma Marketing
Digital Transformation is helping pharmaceutical industry to revisit its business model, to improve processes, and to deliver an authentic customer experience to HCPs in their journey. Companies are now focusing on omnichannel engagement, data driven insights, responsiveness and personalization towards patients and doctors. However, Technology is an Enabler, not a Strategy in itself. It just helps companies to…
Turbocharging Pharma Marketing through Doctor Networks
Product managers and marketers in the pharma industry have spent huge amounts of resources over email marketing, AdSense, and Facebook marketing with an objective to bring doctors to their website. Some have also launched mobile apps and propriety websites only to abandon them midway in absence of any traction between the doctors’ community. A majority,…
ROI on Webinars and Online Events for Doctors
Dive deeper to understand the ROI on Webinars and Online Events Globally, doctors are a busy tribe and getting them involved in any offline activity is becoming challenging every day. The COVID-19 pandemic has made it even harder. Time is a resource which is scarce and valued highly by busy medical professionals. Make no mistake,…
HCP Preference on Effectiveness of COVID-19 Vaccine
Objective: Need to Understand HCP Perception of COVID-19 Vaccine As soon as the COVID-19 outbreak was declared a pandemic, research and studies began on developing a vaccine for the pandemic. It is believed that vaccination against COVID-19 will protect most of the population and help achieve ‘Herd Immunity’. Recently, we conducted a community survey, to…
Neoadjuvant Chemotherapy and Ipilimumab For Stage II-IIIA Non-Small Cell Lung Cancer
Objective of this Therapy Area Insight Immune therapy is increasingly becoming an effective treatment for non-small cell lung cancer (NSCLC). The Objective of this study is to determine the percentage of early stage NSCLC patients with detectable circulating T cells specific against tumor-associated antigen (TAA) after receiving platinum based neoadjuvant chemotherapy plus ipilimumab before surgery.…
